Brachytherapy in the Management of Prostate Cancer

Bradley J. Stish, Brian J. Davis, Lance A. Mynderse, Christopher L. Deufel, Richard Choo

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.

Original languageEnglish (US)
Pages (from-to)491-513
Number of pages23
JournalSurgical Oncology Clinics of North America
Volume26
Issue number3
DOIs
StatePublished - Jul 1 2017

Keywords

  • Dose escalation
  • High dose rate brachytherapy
  • Image guidance
  • Low dose rate brachytherapy
  • Prostate cancer
  • Radiation therapy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Brachytherapy in the Management of Prostate Cancer'. Together they form a unique fingerprint.

  • Cite this

    Stish, B. J., Davis, B. J., Mynderse, L. A., Deufel, C. L., & Choo, R. (2017). Brachytherapy in the Management of Prostate Cancer. Surgical Oncology Clinics of North America, 26(3), 491-513. https://doi.org/10.1016/j.soc.2017.01.008